{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:15:21Z","timestamp":1761549321026,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.nano.2019.102049","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T12:59:18Z","timestamp":1562158758000},"page":"102049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Evaluation of an adjuvanted hydrogel-based pDNA nanoparticulate vaccine for rabies prevention and immunocontraception"],"prefix":"10.1016","volume":"21","author":[{"given":"Amit","family":"Bansal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wael","family":"Gamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianfu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J.","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2019.102049_bb0005","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.vaccine.2017.03.001","article-title":"Rabies: still a silent killer targeting the poor","volume":"35","author":"Wilde","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2019.102049_bb0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.vaccine.2015.11.036","article-title":"Worldwide rabies deaths prevention\u2014a focus on the current inadequacies in postexposure prophylaxis of animal bite victims","volume":"34","author":"Wilde","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2019.102049_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2017.00142","article-title":"Editorial: towards elimination of dog mediated human rabies","volume":"4","author":"D\u00fcrr","year":"2017","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.nano.2019.102049_bb0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2016.08.012","article-title":"Rabies vaccination in dogs using a dissolving microneedle patch","volume":"239","author":"Arya","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2019.102049_bb0025","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jiph.2012.05.002","article-title":"Community perception regarding rabies prevention and stray dog control in urban slums in India","volume":"5","author":"Herbert","year":"2012","journal-title":"J Infect Public Health"},{"year":"2009","series-title":"Alliance for Contraception in Cats & Dogs (ACC&D), Immunocontraceptive approaches for sterilization of dogs and cats, Scientific Think Tank","key":"10.1016\/j.nano.2019.102049_bb0030"},{"key":"10.1016\/j.nano.2019.102049_bb0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.anireprosci.2005.05.032","article-title":"GnRHs and GnRH receptors","volume":"88","author":"Millar","year":"2005","journal-title":"Anim Reprod Sci"},{"key":"10.1016\/j.nano.2019.102049_bb0040","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1016\/j.vaccine.2014.07.075","article-title":"Parenteral administration of GnRH constructs and adjuvants: immune responses and effects on reproductive tissues of male mice","volume":"32","author":"Sharma","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2019.102049_bb0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1600-0897.1993.tb00585.x","article-title":"Progress in the development of anti-LHRH vaccine","volume":"29","author":"Ladd","year":"1993","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.nano.2019.102049_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-4877.2010.00185.x","article-title":"Review of issues concerning the use of reproductive inhibitors, with particular emphasis on resolving human-wildlife conflicts in North America","volume":"5","author":"Fagerstone","year":"2010","journal-title":"Integr Zool"},{"key":"10.1016\/j.nano.2019.102049_bb0055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jbiotec.2015.10.001","article-title":"Humoral immune responses against gonadotropin releasing hormone elicited by immunization with phage-peptide constructs obtained via phage display","volume":"216","author":"Samoylov","year":"2015","journal-title":"J Biotechnol"},{"key":"10.1016\/j.nano.2019.102049_bb0060","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.canlet.2007.10.011","article-title":"Immunization with a recombinant GnRH vaccine conjugated to heat shock protein 65 inhibits tumor growth in orthotopic prostate cancer mouse model","volume":"259","author":"Xu","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.nano.2019.102049_bb0065","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0897.2008.00616.x","article-title":"The single-shot GnRH immunocontraceptive vaccine (GonaCon) in white-tailed deer: comparison of several GnRH preparations","volume":"60","author":"Miller","year":"2008","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.nano.2019.102049_bb0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4142\/jvs.2005.6.1.21","article-title":"Induction of castration by immunization of male dogs with recombinant gonadotropin-releasing hormone (GnRH)-canine distemper virus (CDV) T helper cell epitope p35","volume":"6","author":"Jung","year":"2005","journal-title":"J Vet Sci"},{"key":"10.1016\/j.nano.2019.102049_bb0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1208\/s12248-012-9418-6","article-title":"Biodegradable particles as vaccine delivery systems: size matters","volume":"15","author":"Joshi","year":"2013","journal-title":"AAPS J"},{"key":"10.1016\/j.nano.2019.102049_bb0080","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1016\/j.vaccine.2014.06.009","article-title":"Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination","volume":"32","author":"Pedersen","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2019.102049_bb0085","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.imlet.2017.08.004","article-title":"Enhanced effects of DNA vaccine against botulinum neurotoxin serotype A by targeting antigen to dendritic cells","volume":"190","author":"Chen","year":"2017","journal-title":"Immunol Lett"},{"key":"10.1016\/j.nano.2019.102049_bb0090","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijpharm.2018.05.018","article-title":"Characterization of rabies pDNA nanoparticulate vaccine in poloxamer 407 gel","volume":"545","author":"Bansal","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2019.102049_bb0095","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.biomaterials.2003.08.069","article-title":"Preparation and characterization of cationic PLGA nanospheres as DNA carriers","volume":"25","author":"Ravi Kumar","year":"2004","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2019.102049_bb0100","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ejpb.2008.07.011","article-title":"The influence of chitosan content in cationic chitosan\/PLGA nanoparticles on the delivery efficiency of antisense 2\u2019-O-methyl-RNA directed against telomerase in lung cancer cells","volume":"72","author":"Taetz","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2019.102049_bb0105","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s13233-015-3074-5","article-title":"Serum resistant and enhanced transfection of plasmid DNA by PEG-stabilized polyplex nanoparticles of L-histidine substituted polyethyleneimine","volume":"23","author":"Najafi","year":"2015","journal-title":"Macromol Res"},{"key":"10.1016\/j.nano.2019.102049_bb0110","first-page":"150","article-title":"The effect of cationic charge density change on transfection efficiency of polyethylenimine","volume":"16","author":"Rezvani Amin","year":"2013","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.nano.2019.102049_bb0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0005-2736(96)00242-8","article-title":"Biophysical characterization of cationic lipid: DNA complexes","volume":"1325","author":"Eastman","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nano.2019.102049_bb0120","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0142-9612(03)00605-7","article-title":"Protection of insulin secreting cells from nitric oxide induced cellular damage by crosslinked hemoglobin","volume":"25","author":"Chae","year":"2004","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2019.102049_bb0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1034\/j.1600-065X.2000.917307.x","article-title":"The role of nitric oxide in innate immunity","volume":"173","author":"Bogdan","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1016\/j.nano.2019.102049_bb0130","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1016\/j.vaccine.2005.05.010","article-title":"A synthetic gonadotropin-releasing hormone (GnRH) vaccine for control of fertility and hormone dependent diseases without any adjuvant","volume":"23","author":"Jinshu","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2019.102049_bb0135","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/intimm\/11.7.1103","article-title":"Antigenic and immunogenic properties of totally synthetic peptide-based anti-fertility vaccines","volume":"11","author":"Ghosh","year":"1999","journal-title":"Int Immunol"},{"key":"10.1016\/j.nano.2019.102049_bb0140","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/520200","article-title":"Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity","volume":"29","author":"Romero-Steiner","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nano.2019.102049_bb0145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jconrel.2016.05.058","article-title":"Evaluation of microparticulate ovarian cancer vaccine via transdermal route of delivery","volume":"235","author":"Tawde","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2019.102049_bb0150","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0022-1759(00)00249-0","article-title":"Flow cytometric analysis of intracellular IFN-gamma, IL-4 and IL-10 in CD3(+)4(+) T-cells from rat spleen","volume":"244","author":"Caraher","year":"2000","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.nano.2019.102049_bb0155","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-1759(00)00230-1","article-title":"Flow cytometric measurement of intracellular cytokines","volume":"243","author":"Pala","year":"2000","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.nano.2019.102049_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2019.102049_bb0165","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.vaccine.2004.07.050","article-title":"Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro","volume":"23","author":"Morefield","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2019.102049_bb0170","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1016\/j.vaccine.2011.09.061","article-title":"The mechanism of action of MF59 \u2014 an innately attractive adjuvant formulation","volume":"30","author":"O'Hagan","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2019.102049_bb0175","doi-asserted-by":"crossref","first-page":"202","DOI":"10.7774\/cevr.2014.3.2.202","article-title":"Immunogenicity and efficacy of a plasmid DNA rabies vaccine incorporating Myd88 as a genetic adjuvant","volume":"3","author":"Ullas","year":"2014","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.nano.2019.102049_bb0180","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/S0264-410X(00)00475-8","article-title":"Post-exposure DNA vaccination protects mice against rabies virus","volume":"19","author":"Lodmell","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2019.102049_bb0185","first-page":"221","article-title":"Rabies DNA vaccination by the intranasal route in dogs","volume":"125","author":"Tesoro Cruz","year":"2006","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.nano.2019.102049_bb0190","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1051\/vetres:2007054","article-title":"Intradermal DNA vaccination in ear pinnae is an efficient route to protect cats against rabies virus","volume":"39","author":"Tesoro-Cruz","year":"2008","journal-title":"Vet Res"},{"key":"10.1016\/j.nano.2019.102049_bb0195","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7589\/0090-3558-45.1.184","article-title":"Observations on the use of GonaCon in captive female elk (Cervus elaphus)","volume":"45","author":"Killian","year":"2009","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.nano.2019.102049_bb0200","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1016\/j.vaccine.2013.06.061","article-title":"Concomitant administration of GonaCon\u2122 and rabies vaccine in female dogs (Canis familiaris) in Mexico","volume":"31","author":"Vargas-Pino","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2019.102049_bb0205","first-page":"881","article-title":"Complement activation by aluminium and zirconium compounds","volume":"37","author":"Ramanathan","year":"1979","journal-title":"Immunology"},{"key":"10.1016\/j.nano.2019.102049_bb0210","doi-asserted-by":"crossref","unstructured":"A. Seubert, S. Calabro, L. Santini, B. Galli, A. Genovese, S. Valentini, S. Aprea, A. Colaprico, U. D'Oro, M.M. Giuliani, M. Pallaoro, M. Pizza, D.T. O'Hagan, A. Wack, R. Rappuoli, E. De Gregorio, Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88, Proc Natl Acad Sci U S A 108 (2011) 11169\u201311174. doi:https:\/\/doi.org\/10.1073\/pnas.1107941108.","DOI":"10.1073\/pnas.1107941108"},{"key":"10.1016\/j.nano.2019.102049_bb0215","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1021\/bm4000713","article-title":"Ionization behavior of chitosan and chitosan-DNA polyplexes indicate that chitosan has a similar capability to induce a proton-sponge effect as PEI","volume":"14","author":"Richard","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.nano.2019.102049_bb0220","doi-asserted-by":"crossref","unstructured":"S.T. Reddy, A.J. van der Vlies, E. Simeoni, V. Angeli, G.J. Randolph, C.P. O'Neil, L.K. Lee, M.A. Swartz, J.A. Hubbell, Exploiting lymphatic transport and complement activation in nanoparticle vaccines, Nat Biotechnol 25 (2007) 1159\u20131164. doi:https:\/\/doi.org\/10.1038\/nbt1332.","DOI":"10.1038\/nbt1332"},{"key":"10.1016\/j.nano.2019.102049_bb0225","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.nano.2018.02.007","article-title":"A visible fluorescent nanovaccine based on functional genipin crosslinked ovalbumin protein nanoparticles","volume":"14","author":"Dong","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2019.102049_bb0230","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/(SICI)1097-0290(20000505)68:3<339::AID-BIT12>3.0.CO;2-O","article-title":"Structural stability of DNA in nonaqueous solvents","volume":"68","author":"Bonner","year":"2000","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.nano.2019.102049_bb0235","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/bip.360230711","article-title":"Conformation of P-form DNA","volume":"23","author":"Zehfus","year":"1984","journal-title":"Biopolymers"},{"key":"10.1016\/j.nano.2019.102049_bb0240","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijpharm.2006.11.056","article-title":"Intrapericardial administration of novel DNA formulations based on thermosensitive Poloxamer 407 gel","volume":"331","author":"Roques","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2019.102049_bb0245","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejpb.2014.11.026","article-title":"Modified thermoresponsive Poloxamer 407 and chitosan sol\u2013gels as potential sustained-release vaccine delivery systems","volume":"89","author":"Kojarunchitt","year":"2015","journal-title":"Eur J Pharm Biopharm"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963419301339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963419301339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:10:42Z","timestamp":1761549042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963419301339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":49,"alternative-id":["S1549963419301339"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2019.102049","relation":{},"ISSN":["1549-9634"],"issn-type":[{"type":"print","value":"1549-9634"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of an adjuvanted hydrogel-based pDNA nanoparticulate vaccine for rabies prevention and immunocontraception","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2019.102049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102049"}}